Functional properties of membrane cofactor protein of complement.

The Biochemical Journal
T Seya, J P Atkinson

Abstract

Membrane cofactor protein (MCP or gp45-70) of the complement system is a cofactor for factor I-mediated cleavage of fluid-phase C3b and C3b-like C3, which opens the thioester bond. In the present study the activity of MCP was further characterized. Unexpectedly, in the absence of factor I, MCP stabilized the alternative- and, to a lesser extent, the classical-pathway cell-bound C3 convertases and thereby enhanced C3b deposition. Soluble MCP, if added exogenously, hardly functioned as cofactor for the cleavage of erythrocyte-bound C3b to iC3b; i.e. its activity, compared with the cofactor activity of factor H, was inefficient, since less than 10% of the bound C3b was MCP-sensitive. Further, exogenously added soluble MCP was also a weak cofactor for the cleavage of C3b bound to zymosan. Likewise, factor I, in the presence of cells bearing MCP, cleaved fluid-phase C3b inefficiently. These results imply that MCP has very little extrinsic cofactor activity for factor I. In contrast, exogenously added MCP and factor I mediated efficient cleavage of erythrocyte-bound C3b if the concentration of Nonidet P40 was sufficient to solubilize the cells. Interestingly, soluble MCP and factor I degraded C3b attached to certain solubilized accep...Continue Reading

Citations

Jan 23, 2003·The Prostate·Lena CarlssonGunnar Ronquist
May 24, 2011·Molecular Immunology·Richard J H SmithMatthew C Pickering
Dec 2, 2006·Veterinary Immunology and Immunopathology·Jana AntalíkováLubica Horovská
Apr 5, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L BurdorfR N Pierson
May 4, 2004·Trends in Molecular Medicine·Timothy H J GoodshipJohn P Atkinson
Oct 10, 2006·Molecular Immunology·M Kathryn LiszewskiJohn P Atkinson
Jun 23, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fuminori SakuraiHiroyuki Mizuguchi
Apr 24, 2009·Vaccine·Panisadee AvirutnanMichael S Diamond
Apr 24, 2009·Vaccine·M Kathryn LiszewskiJohn P Atkinson
Nov 3, 2012·Clinical & Developmental Immunology·Sean R StowellJeanne E Hendrickson
Jun 26, 2001·Clinical and Experimental Immunology·C KemperJ P Atkinson
Apr 1, 1992·American Journal of Reproductive Immunology : AJRI·O A VanderpuyeJ A McIntyre
Oct 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anna RichardsTimothy H J Goodship
Jan 1, 1994·Springer Seminars in Immunopathology·B P Morgan, S Meri
Jan 1, 1994·Springer Seminars in Immunopathology·K R KalliD T Fearon
Sep 5, 2009·Nature Reviews. Immunology·Peter F Zipfel, Christine Skerka
May 1, 1995·European Journal of Immunology·L Y WhitemanS Ruddy
Jul 31, 1990·Biochemical and Biophysical Research Communications·T SeyaS Nagasawa
Mar 23, 2007·Gene Therapy·F SakuraiH Mizuguchi
Jul 17, 1999·Journal of Cutaneous Pathology·M WeichenthalE W Breitbart
Jul 1, 1996·European Journal of Immunology·O B SpillerD V Devine
Sep 1, 1999·British Journal of Cancer·N KinugasaT Tsuji
Apr 26, 2005·The Journal of Clinical Investigation·Rebecca C Riley-VargasJohn P Atkinson
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·W G BrodbeckM E Medof
Sep 22, 1994·Proceedings. Biological Sciences·L DrakeD Bundy
May 29, 2004·The Journal of General Virology·Patricia DevauxDenis Gerlier
Aug 14, 2003·Journal of Virology·Anna SegermanNiklas Arnberg
Sep 1, 1993·European Journal of Immunology·M Matsumoto, T Seya
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A M BlomA B Jonsson
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria L Barilla-LaBarcaJohn P Atkinson
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Feng LinM Edward Medof

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.